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Background: It was recently established that changes in methylation during development are dynamic and involve
both methylation and demethylation processes. Yet, which genomic sites are changing and what are the
contributions of methylation (5mC) and hydroxymethylation (5hmC) to this epigenetic remodeling is still unknown.
When studying early development, options for methylation profiling are limited by the unavailability of sufficient
DNA material from these scarce samples and limitations are aggravated in non-model species due to the lack of
technological platforms. We therefore sought to obtain a representation of differentially 5mC or 5hmC loci during
bovine early embryo stages through the use of three complementary methods, based on selective methyl-sensitive
restriction and enrichment by ligation-mediated PCR or on subtractive hybridization. Using these strategies, libraries
of putative methylation and hydroxymethylated sites were generated from Day-7 and Day-12 bovine embryos.
Results: Over 1.2 million sequencing reads were analyzed, resulting in 151,501 contigs, of which 69,136 were
uniquely positioned on the genome. A total of 101,461 putative methylated sites were identified. The output of the
three methods differed in genomic coverage as well as in the nature of the identified sites. The classical MspI/HpaII
combination of restriction enzymes targeted CpG islands whereas the other methods covered 5mC and 5hmC sites
outside of these regions. Data analysis suggests a transition of these methylation marks between Day-7 and Day-12
embryos in specific classes of repeat-containing elements.
Conclusions: Our combined strategy offers a genomic map of the distribution of cytosine methylation/
hydroxymethylation during early bovine embryo development. These results support the hypothesis of a regulatory
phase of hypomethylation in repeat sequences during early embryogenesis.
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Epigenetic marks are defined as enzyme-mediated che-
mical modifications of DNA and/or of its associated
chromatin proteins. Being epigenetic, these marks do
not alter the primary sequence of DNA, but nevertheless
contain information that may be heritable in daughter
cells or potentially transmitted to downstream genera-
tions through germ cells. In plant and mammalian DNA,
the organic base 5-methylcytosine occurs at CpG sites
and accounts for 1–6% of nucleotides. Cytosine methyla-
tion being the most stable epigenetic mark, it is involved* Correspondence: Claude.Robert@fsaa.ulaval.ca
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distribution, and reproduction in any mediumin three vital biological processes in mammals: embryo-
genesis, genomic imprinting and the regulation of tran-
scription [1-3]. Methyl cytosine also occurs at CHG and
CHH sites (where H = C, T, or A) especially in stem cells
[3,4]. Another modified organic base, 5-hydroxymethyl-
cytosine (5hmC), whose presence was revealed in the
nervous system forty years ago [5], has been recently
detected in mice, rats, rabbits and cattle [6-9]. The en-
zyme Tet1 has been shown to catalyse the conversion of
5mC to 5hmC [7] and is reported to regulate develop-
mental processes, neurogenesis and cellular differenti-
ation [10]. Oxidative damage to methyl-CpG sequences
has been reported to inhibit the methyl-CpG binding
domain of methyl-CpG binding protein 2 [11] and
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main is capable of hydroxylating 5mC in vitro at CHG
and CHH sites [14]. The closely related enzymes Tet2
and Tet3 appear to have compensatory roles in undiffer-
entiated tissues or redundant tissue-specific roles in dif-
ferentiated tissues [15] and have been shown in vitro to
play an important role in mouse ES cell lineage specifica-
tion. Their depletion also has an impact on pluripotency-
related genes [16].
These recent data raise questions about the role of
5hmC in methylation reprogramming processes inside
the mammalian zygote. DNA methylation is currently
associated with loss of pluripotency and differentiation,
even though DNA methylation levels do not change very
much during differentiation in mice ES cells [17]. More-
over, genes associated with pluripotency and germ-line
specific genes actually gain methyl groups in the zygote
[18,19]. This indicates that the methylation process
during tissue-differentiation is not general and that
gene-specific or lineage-specific demethylation can occur
through the action of Tet1 [16,17,20]. Several questions
remain, amongst which two are of primary interest:
which genomic sites are actually modified during em-
bryo development, and what are the contributions of
5mC and 5hmC to these changes.
Embryo methylation profiles have been reportedly al-
tered through in vitro procedures [21]. Demethylation
has been reportedly delayed in IVF-derived and ICSI-
derived rat embryos in comparison to in vivo ferti-
lization [22]. The simultaneous study of both 5mC and
5hmC thus could be of great value for the comparison
of in vitro and in vivo embryos. Given that bovine devel-
opmental timing closely follows human developmental
timing, that the impact of in vitro procedures on the bo-
vine methylome has been documented [23,24] and that a
fully annotated Bos taurus genome is available, cattle
offer a good model for the study of methylome and
hydroxymethylome changes during early development in
response to in vitro constraints.
Oxidative Bisulfite sequencing (oxBS-Seq), a recently
developed method for quantifying 5mC and 5hmC, uses
selective oxidation of 5hmC to 5-formylcytosine (5fC) to
enable bisulfite conversion of 5fC to uracil. As 5mC are
the only cytosines not converted to uracil by the proced-
ure, sequencing a sample treated with oxBS allows their
identification. By combining these results with those of
traditional bisulfite sequencing (BS-Seq), which leaves
both 5mC and 5hmC unchanged, the levels of both epi-
genetic marks can be assessed through comparative data
analysis [25]. However, such sequencing-heavy approa-
ches, where each sample must be processed and then
sequenced at least twice, are not compatible with the
generation of multiple profiles from multiple samples in
a cost-effective manner [3]. Alternative high-throughputstrategies focus on reducing sample complexity by using
methylation profiling, either through genomic DNA
restriction by methyl-sensitive endonucleases, bisulfite
conversion strategies or immuno-precipitation using me-
thyl-binding proteins or antibodies against methylcy-
tosine-containing sites [26,27]. Some promising new
methods include GLIB (Glucosylation, periodate oxida-
tion, biotinylation) [14,28] and the anti-CMS protocol
(bisulfite conversion of 5hmC to cytosine-5-methylene-
sulphonate (CMS) followed by immunoprecipitation
using an antibody against CMS) [29]. However, using
the current protocols associated with these methods, we
cannot meet the specific constraint of embryonic epi-
genome analysis, which entails being able to work with a
reduced amount of genomic DNA (< 200 ng) corres-
ponding to a minimal amount of pooled embryos.
We speculate that a well-chosen combination of both
methylation profiling and sequencing-based approaches
should help meet the challenge of building the methy-
lome and hydroxymethylome profile of early mammalian
embryos. Since methylation patterns are tissue-specific,
information on the genome-wide distribution of 5hmC
is still scant for human embryos and model species like
Bos taurus. Consequently, in order to perform a first ex-
ploration of 5mC and 5hmC representation in mamma-
lian embryos, we sought to develop a strategy for the
rapid generation of differently methylated regions. The
methyl-sensitive restriction-based strategy proposed
herein is a high-throughput approach providing a gen-
omic mapping of 5mC and 5hmC-containing sequences
with uniform coverage by using different sets of methyl-
sensitive enzymes. We combined three protocols to
obtain a comprehensive survey of candidate 5mC and
5hmC sites during early bovine development: an adap-
ted methyl-sensitive representational difference analysis
(Me-RDA) protocol [30] using a MspI/HpaII isoschizo-
mer system [31], a variation using FspBI/BfaI isoschi-
zomers to reveal hydroxymethylation (HMe-RDA) and
enzymatic cocktail-enrichment ligation-mediated PCR
protocol (“HELP cocktail”) adapted from Schumacher
et al. (2006) [32]. This combined strategy allowed the
profiling and mapping of an important amount of me-
thylated and hydroxymethylated sites in early develop-
mental stages.
Results
All three of the library construction methods are based
on selective restriction cleavage using some combination
of methylation/hydroxymethylation-sensitive and methy-
lation/hydroxymethylation-insensitive enzymes. The aim
of each restriction enzyme combination was to identify
both 5mC and 5hmC as well as to offer extended ge-
nomic coverage.
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Methylation-sensitive representational difference analysis
(Me-RDA) is a protocol composed of traditional RDA
methodology [33] which combines methyl-sensitive and
methyl-insensitive endonucleases for the identification of
hypo- and hyper-methylated DNA fragments [34,35]. Its
underlying mechanism uses PCR, subtractive hybridi-
zation and kinetic enrichment to amplify a set of restric-
tion fragments present in one sample (Tester, cleaved
with a methyl-insensitive endonuclease) but not the
other (Driver, cleaved with a methyl-sensitive endonu-
clease). Adaptors are ligated only to the Tester fraction.
When subtractive amplification is performed, only Tester-
Tester homodimers are exponentially amplified while
Tester-Driver heterodimers follow a linear amplification
and progressively become underrepresented. The resulting
enrichment in Tester-Tester homodimers constitutes in-
direct evidence that there are no corresponding amplicons
in the Driver representation, indicating that the corre-
sponding restriction sites remained uncut, presumably be-
cause they were completely or partially methylated.
Our strategy for the enrichment of methylated ge-
nomic loci is based on a modified protocol of Me-RDA
and is illustrated in Figure 1A. It uses MspI as its
methyl-insensitive endonuclease, and its isoschizomer
HpaII as its methyl-sensitive endonuclease [31]. As the
cleaving activity of both MspI and HpaII have been
shown to be either inexistent or severely inhibited in the
presence of an internal 5hmC [36], only 5mC bearing
sites should be enriched by the procedure. Enrichment
of the MspI fraction is confirmed when intense bands
are revealed by electrophoresis. Bands for the MspI frac-
tion could be obtained following a single round of sub-
tractive amplification using a 1: 100 hybridization ratio
of Tester and Driver DNA (Figure 2A, smear H). We
chose hybridization conditions (>24 h) where the cot
value allows nearly 100% of complementary template
hybridization in complex genomes, including all non-
repetitive sequences. The subtraction having been suc-
cessful, we chose to limit it to a single round in order to
target partially methylated sites, which are underrepre-
sented and could thus be eliminated through a second
round of subtraction. The experimental range of vali-
dated amplicons for RDA methods is between 100 bp
and 4 Kb, depending on the enzymes used [30,33]. In
the present study, the validation range for MspI/HpaII
Me-RDA amplicons was between 100 bp and 1 Kb (data
not shown).
HMe-RDA strategy: targeting 5hmC sites
Given the potential involvement of the recently discovered
5hmC mark in the epigenetic regulation of important bio-
logical processes, we decided to develop a modified Me-
RDA protocol that uses a hydroxymethylation-sensitiveendonuclease. By reviewing the restriction enzyme data-
base REBASE [37], we found a pair of isoschizomers,
namely BfaI (sensitive) and FspBI (insensitive) to as-
sess the hydroxymethylation status of cytosines. Fol-
lowing the Me-RDA experimental design, Tester DNA
was cleaved with FspBI and Driver DNA was cleaved
with BfaI (see method, Figure 1A). By using the same
method to obtain hydroxymethylome data as was
used to obtain methylome data, it was expected that
the datasets would be comparable. Furthermore, in
order to target both methylation and hydroxymethy-
lation (or other base modifications) in the same reac-
tion, it is possible to use a cocktail containing several
restriction enzymes providing –TA protruding ends.
This can be achieved by extending the HMe-RDA
protocol into an RDA cocktail protocol, using the
same set of JTA and NTA primers. For simple, double
or triple cleavage generating –TA ends, we designed
adaptors creating a new BfaI/FspBI site for subsequent
adaptor removal. As a preliminary test, we successfully
performed a Me-RDA cocktail protocol with double di-
gestion of two –TA overhang restriction enzymes (BfaI
and Tru1I) (Figure 2B, smear B).
HELP cocktail strategy: targeting 5mC in non-CpG regions
A study from Schumacher and colleagues describes the
benefits and limitations of strategies targeting both
unmethylated and hypermethylated fractions [32]. In
spite of showing in silico that the unmethylated fraction
derived from HpaII cleavage results in ~ 22 times more
fragments than the hypermethylated fraction derived
from MseI, they proposed an informative approach
based on enrichment of the hypermethylated fraction,
which can improve information on methylated sites in
distinct genomic regions. We thus chose to complement
our Me-RDA 5mC data with a protocol based on the
Schumacher strategy, of which the hypermethylated
DNA fragment enrichment relies on frequent cutter TasI
(/AATT) cleavage (Figure 1B). TasI sites are infrequent
within GC-rich regions, leaving most CpG islands intact.
After ligation to AATT-overhang specific adaptors, the
unmethylated and hypo-methylated fragments were
cleaved with a cocktail of methyl-sensitive endonucleases
(HpaII, Aci1I and HinP1I) in order to impede their fur-
ther amplification. The resulting fraction was enriched
in hypermethylated fragments that escaped digestion
and was therefore subsequently amplified. On the resul-
ting gel, we observed that the successful amplification of
methyl-sensitive cocktail digestion transforms the elec-
trophoretic smear by removing intense bands and redu-
cing fragment size (Figure 2B: see smears PCR1 and
PCR2, respectively before and after methyl-sensitive
digestion).
Figure 1 Schematic illustration of procedures for the three methodologies used to survey embryo methylome and hydroxymethylome.
A) Me-RDA and HMe-RDA methodologies use hybridization and subtraction between Tester DNA cleaved with an insensitive enzyme and Driver
DNA cleaved with a sensitive isoschizomer. White circle: unmethylated cytosine; orange circle: methylated cytosine. 1 The subtractive PCR includes
a single-strand DNA digestion step by a mung bean nuclease after 10 cycles of amplification and is followed by 20 cycles of amplification. B) HELP
Cocktail methodology. Following TasI ligation mediated-PCR, amplification products are digested with a methyl sensitive enzymatic cocktail.
Methylated fragments remain uncut, and are subject to exponential amplification in a final PCR.
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Figure 2 Resulting smears of amplifications of blastocyst DNA
from the three protocols. A) Resulting smears of amplifications
from Me-RDA and HMe-RDA methodologies. One round (R1) of
kinetic enrichment results in a HpaII site-enriched smear (H) and a
BfaI site-enriched smear (B) with PCR control for HpaII (T-H) and PCR
control for BfaI (T-B). L: 100 pb ladder. B) Resulting smears from
HELP Cocktail methodology. TasI ligation mediated-PCR (PCR1). Final
PCR (PCR2).
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Using these three protocols, selected genomic libraries
were prepared for blastocysts (Day-7) and elongated
embryos (Day-12). The extent of DNA cleavage was
assessed in terms of intact sites in methylation-
insensitive digestions. Results show reactions are > 90%
complete (Table 1). Read length averaged 235 bp for a
total of 1,283,097 analyzed reads (Tables 1 and 2). The
number of clean reads per library was between 71,459
and 281,619 (Table 2). The enzyme pair targeting 5hmC
generated the lowest number of clean reads for both de-
velopmental stages (Table 1). The HELP cocktail strategy
required an extra step to filter contaminating fragments
that did not harbour an internal restriction site. In the
HELP cocktail strategy, TasI cleavage generates frag-
ments with protruding TasI ends that may or may not
contain methyl-sensitive sites. Digestion by a cocktail of
methyl-sensitive enzymes will cut TasI-TasI fragments if
they contain unmethylated internal HpaII, AciI or




Average raw read length (base pair)a 285 ± 121 23
Reads with internal genomic digestion siteb 17 429 (6.2%) 354
Putative methylated restriction sites within CpG Islandsc 1198 (33.4%) 455
aWith standard deviation. bNumber of cleaned reads (percentage of all cleaned read
more than 10 nucleotides from the ends. Such sites are indicative of incomplete ge
CpG islands over the total number of sites identified for this library. As a reference,be enriched in TasI-TasI fragments containing methyl-
ated HpaII, AciI or HinP1I sites or fragments containing
no such sites. In silico analysis was used to discard the
latter fragments (without HpaII, AciI or HinP1P sites),
which brought no information on genome methylation
status. If redundancy is removed, the portion of HELP
cocktail fragments containing at least one expected re-
striction site and considered as real positives is about
20% of the identified contigs (Table 1). The number of
contigs was comparable for all libraries with an average
of 31,039 ± 6,165 consensus sequences.
As expected, the genomic alignment of contigs
resulted in a high proportion of mapped loci. For bovine
genome sequences that could not be mapped, further
analysis ruled out linker concatemerization. However
the presence of numerous shorter contigs could not rule
out potential chimeric fragments or the identification of
still unmapped bovine genomic sequences. The propor-
tions of unmapped contigs were the highest for libraries
targeting 5mC in CpG islands and 5hmC in Day-12 em-
bryos (Table 1). BLAT results also showed that a large
proportion of contigs aligned with multiple locations of
the genome. This situation was particularly evident for
the method targeting 5mC in CpG islands (Me-RDA),
since only 6-7% of the contigs could be positioned un-
ambiguously on the genome. These proportions were
much higher for the other methods with 46% (Day-7)
and 59% (Day-12) for 5hmC contigs and 58% (Day-7)
and 81% (Day-12) for 5mC contigs (Table 1). These
values corroborated our results with respect to repetitive
content as well as the positioning of the contigs within
CpG islands. More than 30% of the contigs isolated
using Me-RDA mapped to CpG islands whereas only
2-4% of the contigs found with the other methods
mapped to these CpG-rich domains (Table 2).
Chromosomal mapping of consensus sequences
In order to evaluate the qualitative distribution of
mapped sequences along bovine chromosomes, a chro-
mosomal mapping of the 69,136 putative methylated
regions was generated and plotted alongside genomic
coverage data for genes and CpG islands as well as a
cytoband mapping adapted from Liao et al. [38]. Anyst embryos Elongation embryos
e-RDA HELP cocktail Me-RDA HMe-RDA HELP cocktail
BI/BfaI Msp/Hpa FspBI/BfaI
5 ± 142 257 ± 113 274 ± 132 115 ± 87 241 ± 142
7 (4.8%) 23 396 (10.0%) 15,245 (7.9%) 2134 (3.0%) 9037 (4.1%)
(2.1%) 313 (1.7%) 899 (34.8%) 546 (3.5%) 1583 (4.0%)
s) containing an intact site for a methyl-insensitive restriction endonuclease
nomic cleavage. cThe percentage of putative methylated restriction sites within
CpG islands cover 1.9% of the bovine genome.
Table 2 Bioinformatics analysis pipeline for the identification of putatively methylated sites
Blastocyst embryos Elongation embryos All
Method Me-RDA HMe-RDA HELP cocktail Me-RDA HMe-RDA HELP cocktail
Msp/Hpa FspBI/BfaI Msp/Hpa FspBI/BfaI
Raw reads from library 313 330 179 105 242 864 208 963 94 961 243 874 1 283 097
Cleaned readsa 281 619 72 855 234 149 192 163 71 459 218 874 1 071 119
Validated readsb N/A N/A 46 835 N/A N/A 50 462 N/A
Consensus sequencesc 33 123 29 416 31 604 25 616 24 963 41 784 186 506
Sequences with genomic alignmentsd 28 941 25 360 25 519 18 944 14 978 37 759 151 501
Sequences with unique alignmente 1890 11 772 14 712 1317 8858 30 587 69 136
Putative methylated restriction sitesf 3634 21 352 18 810 2584 15 714 39 367 101 461
aNumber of reads left after cleaning with SeqClean. Reads smaller than 25 nt after adapter trimming were discarded. bFor HELP, number of reads with an internal
HpaII, AciI or HinP1I restriction site. cNumber of consensus sequences after clustering with a 97% identity threshold. dNumber of consensus sequences with a
BLAT genomic alignment with 92% identity over 92% of the length of the transcript. eNumber of consensus sequences for which a single alignment fits the above
criteria. fNumber of potentially methylated sites identified in the genome through the alignment and extension of reads. N/A = not applicable.
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found in Additional file 1: Figure S1, while the data itself
can be visualized directly on the EmbryoGENE genome
browser (http://emb-bioinfo.fsaa.ulaval.ca/). We observe
that the combined site distribution follows neither CpG
islands nor genes and covers the entire genome. Overall,
all three methods provided a distribution across the en-
tire genome and were shown to target different loci, thus
providing wide coverage.
Establishment of 5mC and 5hmC marks within repeated
elements
Characterization of the repetitive elements within the
consensus sequences of the libraries (Table 3) showed
that Me-RDA sequences were enriched in satellite ele-
ments (87.7% and 91.7% of total bases for Day-7 and
Day-12 embryos respectively). Furthermore, BTSAT4 ac-
counted for 94.4% and 88.9% of satellite loci in the Day-7
and Day-12 embryo libraries respectively (Additional
file 1: Table S2). Since centromeres and telomeres are
repeat-rich regions, a genomic coverage plot of BTSAT4Table 3 Repetitive content in consensus sequences
Blastocyst embryos
Method Me-RDA HMe-RDA HE
Msp/Hpa FspBI/BfaI
Number of sequences with
repetitive contenta







Repetitive content as identified by RepeatMasker. aNumber of sequences (percenta
number of bases within the consensus sequences of the given library. cAs a referenelements was generated to confirm the increased presence
of centromeric and telomeric loci within the contig collec-
tions generated by Me-RDA (Additional file 1: Figure S2).
By comparison, the abundance of BTSAT4-associated loci
in HMe-RDA libraries suggests a transition in the estab-
lishment of the 5hmC mark between Day-7 and Day-12,
since this specific sequence went from accounting for
13.5% of repeat-containing contigs in the Day 7 li-
brary to 31.7% in the Day-12 libraries. In contrast,
BTSAT4 showed low representation in the HELP
cocktail libraries (0.9% and 0.5% for Day-7 and Day-
12 respectively) (Additional file 1: Table S2).
Retrotransposons also occupy a large contingent of the
identified repeated elements. Among the retrotranspo-
sons that were identified, the short interspersed ele-
ments were found more abundant in the HELP cocktail
libraries, which were shown to target more 5mC outside
of CpG islands than did the other two libraries. More-
over, these sequences seem to be more methylated in
Day-7 compared to Day-12 embryos (Table 3). The long
interspersed elements were proportionally more prevalentElongation embryos
LP cocktail Me-RDA HMe-RDA HELP cocktail
Msp/Hpa FspBI/BfaI
27 055 21 490 11 058 26 453
(85.6%) (83.9%) (44.3%) (63.3%)
47.2% 0.3% 6.4% 30.1%
17.3% 0.1% 10.0% 10.5%
2.1% 0.4% 5.4% 4.5%
3.9% 91.7% 25.6% 3.4%
71.9% 92.6% 47.9% 50.0%
ge of total) within which repetitive content was found. bPercentage of the total
ce, annotated repetitive elements cover 48.1% of the bovine genome.
Table 4 Distribution of types of genomic regions within
which putative methylated/hydroxymethylated
restriction sites were identified
Region type Genomica MeRDA HMe-RDA HELP cocktail
Promoters 3.3% 4.1% 4.1% 3.0%
Exons 1.8% 12.5% 2.1% 5.0%
Introns 32.2% 38.6% 36.9% 42.1%
Intergenic 62.7% 44.7% 56.8% 49.9%
aAll differences between genomic proportions and library proportions were
found significant (P < 10-4).
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was more evident for the 5hmC marks (Table 3).
Functional mapping between methods
To study the distribution of identified loci according to
gene functional units, the genome was divided into pro-
moter, exon, intron and inter-gene regions based on
known gene structure. Gene promoter regions were de-
fined arbitrarily as starting 5 kb upstream from the
transcription initiation site. Since the coverage and dis-
tribution of putative methylated sites throughout the
genome was similar across developmental stages, the
dataset of both Day-7 and Day-12 embryos were com-
bined for each library preparation methodology. Both
epigenetic marks were found in every functional classifi-
cation (Figure 3 and Table 4). The distributions of 5mC
and 5hmC containing loci were quite similar across
methods. The [Day-7 + Day-12] library proportions of
promoter, exon, intron and inter-gene regions were
found significantly different from the whole-genome pro-
portions of those same regions (P < 10-4). Also, 5mC sites
isolated using Me-RDA seemed more prevalent in exons.
Mark-specific and stage-specific transition
Since methylation is involved primarily in embryogenesis
and development, while hydroxymethylation is involved
notably in differentiation, methylated sequences may
change during embryonic lineage differentiation taking
place between the blastocyst stage (Day-7) and the be-
ginning of the elongation stage (Day-12). To measure
this, we compared the location of identified putative
methylated sites between blastocyst and elongation sta-
ges for each method (Figure 4). The absolute number of
Me-RDA 5mC regions is reduced from Day-7 to Day-12,
but the elongated stage displays 687 specific new regions
(70% of Day-12 regions). The number of HMe-RDA
regions also decreased slightly from days 7 to 12, but
Day-12-specific new 5hmC regions still represented
48.61% of total Day-12 regions. Conversely, the absolute
number of HELP cocktail 5mC regions increased fromFigure 3 Distribution of putative methylated/hydroxymethylated
restriction sites among the genomic region types. Genomic values
are provided as a neutral reference.Day-7 to Day-12 with the latter displaying 4,737 specific
new regions (57% of Day-12 regions). Moreover, if we
compare the portion of common or specific regions of
all methods (Figure 5), the portion of specific Me-RDA
5mC regions is the lowest (25% of total Me-RDA re-
gions) and is comparable to specific HMe-RDA regions
portion (28% of total HMe-RDA regions), while the por-
tion of specific HELP 5mC regions is noticeably higher
(46% of total HELP cocktail regions). These observa-
tions show that the HELP cocktail method is likely an
informative sensor of methylated transition sequences
during elongation in bovine early embryos. The location
of at least a quarter of 5hmC-containing sequences in
different regions from 5mC illustrates a potential role of
specific 5hmC regions during the blastocyst-to-elon-
gation (Day-7 to Day-12) transition, which could be in-
dependent of 5mC location.
q-PCR methylated and hydroxymethylated profiles
During the initial validation tests performed by non-
quantitative PCR on putative methylated candidates
from granulosa cells obtained from one round of Me-
RDA protocol, 78% of the 20 candidates showed differ-
ential intensity profiles between Tester and Driver (data
not shown). For candidate embryonic sequences, subsets
of selected repeated elements were targeted by q-PCR
comparing the differences in amplification rates between
aliquots of the same samples submitted to restriction
digest either by mark-sensitive or insensitive enzymes
[39] (Additional file 1: Table S1). For all three methods
(Me-RDA, HMe-RDA, HELP Cocktail), 74% of the 23
sequences tested were validated to be partially me-
thylated or hydroxymethylated. For both RDA based
approaches combined (Me-RDA/HMe-RDA), 77% of
candidate sequences were found to be methylated or
hydroxymethylated and for HMe-RDA, all of the six
tested candidates were found to be hydroxymethylated.
On the 17 subsets of repeated elements selected from
Me-RDA and HMe-RDA that validated, eleven and six
candidates targeted methylation and hydroxymethylation
respectively (Figure 6). None of the 5mC mark can-
didates showed significant differences between Day-7
and Day-12 stages. Amongst the six hydroxymethylation
Figure 4 Number of methylated/hydroxymethylated restriction sites in the same genomic region for each protocol.
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and BTSAT6, were tested and found significantly different
between Day 7 and Day 12 embryos (P = 0.0035 and
P = 0.0154, respectively). The 5hmC-containing BTSAT4
candidate displays multiple loci amongst the genome,
whereas the BTSAT6 sequence includes the RGL1 gene
locus (5hmC Targets 2 and 3, Additional file 1: Table S1).
The hydroxymethylation of this BTSAT6 sequence was
significantly decreased in the RLG1 locus of elongated em-
bryos. The RLG1 locus is reported to be involved in the
cellular response to DNA damage and the mainten-
ance of chromosomal integrity, both regulated by me-
thylation [40,41].
Discussion
This epigenomic survey based on methyl-sensitive re-
striction was inspired by earlier studies like the HELPFigure 5 Overlap of methylated/hydroxymethylated
genomic regions.assay [42,43] and unmethylated and methylated fraction
enrichment strategies [32,44] but also by improvements in
next-generation-sequencing-based technologies [26,45,46]
and especially by the recently studied methylation mark
5hmC [15,47].
While adapting Me-RDA and HELP protocols to high-
throughput objectives, the combined 5mC and 5hmC pro-
filing strategy addressed methodological challenges and
resulted in several advantages. Restriction-enzyme-based
methods are usually used to enrich either the unmethyl-
ated or the hypermethylated fraction of gDNA. Since the
HELP cocktail targets CpG-rich regions both inside and
outside CpG islands with an estimated CpG dinucleotide
coverage of 32% [32], it overcomes the main disadvantage
of the simple HELP (simple HpaII digestion) assay which
offers significantly lower genomic coverage [26]. In this
combined approach, the HELP cocktail method, which
provides enrichment of the hypermethylated fraction, is
the most informative protocol. The HELP cocktail library
displays the greatest coverage of gene and inter-gene re-
gions, while the other protocols (Me-RDA and HMe-RDA)
provided unique sets of complementary loci of interest, es-
pecially within satellite elements. The three protocols also
display specific abilities. The TasI frequent cutter used in
the HELP cocktail provides a fraction containing methyl-
sensitive sites that escape GC site enrichment because of
restriction site incompatibility. By including a subtractive
amplification, Me-RDA and HMe-RDA can enrich
rare fragments or sequences difficult to amplify be-
cause of fragment size or base content that would
not have been enriched using a single ligation-
mediated HELP PCR. Moreover, Me-RDA preferen-
tially targets exon sequences, in contrast with HELP
and HMe-RDA protocols, which can be explained by
the large number of CpG islands in exons. Thus, the
objective of discovering widely distributed candidate
regions was achieved.
Differing reports on the genomic locations of 5hmC
can be explained by either tissue or method-specific
differences. The HMe-RDA dataset indicated high levels
of 5hmC-containing sequences in inter-gene locations
Figure 6 Inter-stage comparison of methylation/hydroxymethylation status of selected subsets of loci. Aliquots of samples were digested
using either mark-sensitive or insensitive enzymes. The differences in amplification rates relates to the methylation (5mC or 5hmC) status.
Different letters means statistically significant value P < 0.05.
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5hmC in mouse Embryonic Stem cells (mES) shows 30%
inter-gene location [10]. Nevertheless, a recent study on
mouse pre-implantation embryos reported that highly
methylated CpG islands are intra-gene, which can be
explained by enhanced maintenance of methylation or
resistance of non-imprinted sequences to demethylation
[48]. Moreover, a microarray-based study of individual
mouse blastocysts showed that 90% of the most methyl-
ated loci overlap with exons [49]. Since RDA strategies
are known to amplify hypermethylated sequences, this
can explain the overrepresentation of inter-gene loca-
tions and the high representation of repeats in the Me-
RDA and HMe-RDA libraries.
A crucial advantage of applying PCR-based combined
methylation and hydroxymethylation profiling to embryo
epigenomics is the ability to reduce the requirement of
input DNA by using optimized ligation and amplifica-
tion. Each of the three protocols requires about 200 ng
of genomic DNA, but improving PCR yield allowed suc-
cessful representation starting with as little as 50 ng of
DNA corresponding to an average of 200 pooled blasto-
cysts. None of the current methylation or hydroxy-
methylation profiling methods (such as MethyCap-seq,
HMedIP, GLIB or anti-CMS) can meet such constraints
as they all require between 1 and 10 μg of starting DNA.
Yet these approaches benefit from several advantages
such as higher signal-to-noise ratio (especially for GLIB)
[28] resulting in less false positives than in our res-
triction-based approach (Additional file 1: Table S3).
Contrary to the random DNA fragmentation by sonic-
ation used within GLIB, our representation strategy is
based on enzymatic restriction and yields predictable
DNA fragments. This does not prevent our method
from achieving uniform coverage of the bovine gen-
ome (Additional file 1: Figure S1), which met our ob-
jective of discovering and mapping new 5mC and
5hmC-containing sequences without any topological
bias. In contrast with GLIB, our approach deliberately
targets repetitive elements such as BTSAT4 and BTAST6
which are demonstrated by q-PCR validations to be
candidates for transitory 5hmC marks during bovine
embryogenesis.
Repetitive sequences are largely represented in a
method-specific manner with prevalence of satellites in
Me-RDA libraries and long interspersed elements
(LINEs) in HELP libraries. Repetitive sequences are also
represented in a stage-specific manner, notably for the
HMe-RDA library. Previous studies using HpaII-methyl-
sensitive RDA show the ability of the subtractive method
to target repetitive sequences in tumors [50,51]. An in-
teresting study in mice reports that 66% of isolated
hypomethylated sequences correspond to LINE-1, LTR
or SINE sequences [52]. The LINEs were proportionallymore prevalent in the Day-7 than in the Day-12 HMe-
RDA libraries confirming very recent data in mice show-
ing that LINE-1 display an important amount of 5hmC
and are reprogrammed during preimplantation deve-
lopment that is before differentiation processes [25]. In
addition, it seems that satellite sequences in particular
could be considered as possible candidates to target me-
thylation and hydroxymethylation changes when com-
paring Day-7 to Day-12 bovine embryos. A previous
comparison of methylation levels of repetitive loci dur-
ing bovine development revealed that satellites I and II
are hypo-methylated in blastocysts [53], consistently
with studies hypothesizing that satellite demethylation
occurs very early in the germ cell lineage, prior to entry
into meiosis [54]. Given the hypothetical role of hydro-
xymethylation in oxidative demethylation, the increase
in hydroxymethylation of bovine satellite sequences ob-
served in HMe-RDA between Day-7 (13.9%) and Day-12
(25.2%) would be consistent with methylation removal
associated with the differentiation of primordial germ
cells in the early embryo genome which begins to hap-
pen in elongated bovine embryos [2]. Furthermore, it
was shown that satellite I methylation decreased signifi-
cantly in the trophectoderm but not in the embryo in
somatic cell nuclear transfer embryos in comparison to
in vivo embryos at the elongation stage (Day-12) [55].
The slight enrichment of 5hmC in satellite sequences in
our blastocyst embryos and its associated putative de-
methylation could therefore be an effect of in vitro
conditions.
One possible explanation for 5hmC enrichment of
specific loci in Day-12 elongated embryos linked with
putative demethylation could be the role of trophecto-
derm-specific methylation status. Indeed, Long Terminal
Repeats (LTR) are significantly higher in HMe-RDA li-
braries, in particular at Day-12 stage, indicating a 5hmC
enrichment within retrotransposons between blastocyst
and elongation stages (Table 3). Consistent with this is a
description of a role for endogenous retrovirus in tro-
phoblast differentiation and placental development [56].
To address further on the question of a specific role of
the trophectoderm in the overall 5hmC enrichment ob-
served within LTR at elongation stage, embryonic tissue
dissection will be necessary.
Another question of interest concerns the possibility
of opposing 5mC and 5hmC marks. Several reports sup-
port the claim that 5hmC action maintains or promotes
gene expression in opposition to 5mC [57] or represent
a transition step and partially overcomes the silencing
effect of 5mC [58]. Representation of certain 5mC marks
and 5hmC marks was therefore expected to differ be-
tween Day-7 and Day-12 embryos.
The assumption regarding the specific regulatory role
of 5hmC in differentiation processes is consistent with
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specific sequence composition, poised chromatin con-
figuration and gene expression upon differentiation
[14,59,60]. In fact, activation of lineage-specific loci can
occur either via a postulated 5mC demethylation path-
way or through recruitment of transcriptional regulators
that specifically recognize 5hmC and become activated
in response to differentiation signals. For example, ac-
quisition of 5hmC in cell-specific distal regulatory re-
gions is expected to activate enhancers and participate
in selective activation of tissue-specific genes in neural
and adipose tissues [60]. A connection between 5hmC
and regulatory elements appears likely in our data, since
5hmC is enriched upstream and downstream of Tran-
scription Start Sites (TSS), while 5mC is enriched pri-
marily downstream of TSS [14]. We observed that 4% of
the resulting unique 5hmC sites for both the Day-7 and
Day-12 embryos were located in the region 5 kb up-
stream from TSS indicating a possible regulatory role of
5hmC mark on its own.
More generally, our data raise questions about the role
of 5hmC in the dynamic status of methylation inside the
mammalian zygote during early developmental stages.
An overall and differential loss of methylation happens
in the first few days of development in mammals. In the
paternal genome, demethylation occurs through an ac-
tive enzymatic process, whereas the maternal genome
apparently undergoes passive replication-dependant de-
methylation [61-63]. Recent data showed that 5hmC
accumulated in the paternal pronucleus while 5mC de-
creased, supporting the model of Tet3 conversion of
5mC into 5hmC [9,64]. In mice, a second wave of de-
methylation in the maternal genome is normally com-
pleted by the time the embryo reaches the morula stage.
Then, from the morula stage until the blastocyst stage,
an increase in de novo methylation takes place [65]. But
most recently, a study published by Smith and col-
leagues provides new insights into the two developmen-
tal transitions in DNA methylation occuring between
the sperm and the zygote and between the early inner
cell mass and the post-implantation embryo [66]. They
observe that methylation levels reflect a global subtle
but gradual decrease in mice post-implantation embryos.
Consistently with our data, the most extreme changes
are for sequences enriched for repeat elements: 18% of
LINEs and 10% of LTR reduce significantly their methy-
lation values. In our study, not only methylation levels at
specific loci decrease, but also hydroxymethylation levels
change indicating a role of 5hmC at specific repetitive
sequences in the developmental transition around the
period initiating foeto-maternal interactions. Further-
more, methylcytosines are likely to be targeted for com-
plete demethylation since some 5hmC levels decrease
between blastocyst and elongation stages for specificloci. This suggests that a subsequent oxidation of 5hmC
into 5fC could happen, possibly followed by decarboxy-
lation into 5caC as recently hypothesized [67].
Conclusions
Numerous recent reports indicate the epigenetic top-
ology of DNA vary both following normal differentiation
processes and in response to developmental constraints.
By combining restriction-based strategies, we provide
here an important amount of genomic data illustrating
two interesting points: first, the use of optimized RDA
and HELP protocols in order to create two annotated
maps identifying a total of 69,136 putative methylated
and hydroxymethylated cytosines in the bovine genome
during embryogenesis; secondly, the analysis of the
obtained data in the context of bovine early embryonic
development.
Thanks to a combined study of 5mC and 5hmC marks
and the slower developmental kinetics of the bovine em-
bryo compared to the mouse model, we were able to
propose a complementary findings to those of Smith
et al. [66] by showing that the unique regulatory phase
of hypomethylation occurring during the blastocyst stage
also lasts through differentiation (i.e. elongation-asso-
ciated processes in the bovine embryo). Our data suggest
that this hypomethylation status corresponds to a de-
methylation process with methylated cytosines at specific
repeats (mostly Satellites and LTR) being converted to
5hmC during the blastocyst-elongation stage transition
and likely to be targeted for complete demethylation.
The quality of our data is compatible with the design
of an oligoset targeting these putative DNA methylation
sensitive loci which is the basis for the ongoing develop-
ment of a dedicated microarray-based platform for the
purpose of systematic querying of the status of 5mC/
5hmC marks during early development when submitted
to environmental stresses.
Methods
All reagents were obtained from Sigma-Aldrich (St-Louis,
MO, USA) unless otherwise specified.
Embryo in vitro production
Dairy cattle ovaries from a commercial slaughterhouse
were transported to the laboratory in saline (0.9% NaCl)
containing 1% antimycotic agent. Cumulus oocyte com-
plex (COC) collection was conducted within 2 h of re-
ception. COCs were aspirated from 2–6 mm follicles.
Healthy COCs with at least five layers of cumulus were
selected for maturation. Cumulus-oocyte complexes with
fragmented cytoplasm, pyknotic cumulus, pale nuclei and
abnormal morphology were rejected.
The COCs were washed in HEPES-buffered Tyrode’s
medium (TLH) supplemented with 10% bovine serum,
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of ten healthy COCs were placed in 50-μL droplets of
medium under 9 mL of filtered mineral oil. Maturation
medium was composed of TCM199 (Gibco 11150–059;
Invitrogen, Burlington, ON, CAN), 10% foetal bovine
serum (Sterile Fetal Bovine Serum for Cell Culture,
Medicorp, Montréal, QC, CAN), 200 μm pyruvate,
50 μg/mL of gentamycin and 0.1 μg/mL of follicle stimu-
lating hormone (FSH) (Gonal-f, Serono Canada Inc.,
Mississauga, QC, CAN). Droplets containing COCs were
incubated for 24 h at 38.5°C with 5% CO2, 20% O2 and
high humidity.
Matured COCs were washed twice in TLH. Groups of
five matured COCs were added to 50-μL droplets of
medium under filtered mineral oil. Each droplet con-
sisted of modified Tyrode’s lactate medium, supplemen-
ted with 0.6% bovine serum albumin (Sigma fraction V),
40 mM pyruvate and 50 μg/mL gentamycin. A solution
1 mM hypotaurine, 2 mM penicillamine and 250 mM
epinephrine was then added (2 μL) to the COC-con-
taining droplets. The cryo-preserved pool of spermatozoa
came from five Holstein bulls (Centre d’insémination
artificielle du Québec). Semen was thawed in water at
37°C, laid on a discontinuous Percoll gradient (2 mL of
45% Percoll over 2 mL of 90% Percoll) and centrifuged at
700 × g for 30 min at room temperature. The pellets were
re-suspended in in vitro fertilization medium to obtain a
ratio of 50,000 spermatozoa/droplet. Fertilization took
place in an incubator for 15–18 h at 38.5°C with 5% CO2,
20% O2 and high humidity.
Zygotes and unfertilized COCs were mechanically de-
nuded by repeated pipeting and washed twice in TLH to
ensure complete removal of cumulus cells. For standard
culture conditions, groups of ten embryos were placed
in 10-μL droplets of modified synthetic oviduct fluid
(SOF) under filtered mineral oil [68]. Sequential SOF
media were used as described previously [69]. The em-
bryos were first placed in SOF#1 (6 mM lactate, 0.2 mM
glucose). The embryo culture dishes were incubated
38.5°C with 6.5% CO2, 5% O2 and high humidity. Em-
bryos were transferred to droplets of SOF#2 (1 mM lac-
tate, 0.5 mM glucose) 72 h after fertilization and to
droplets of SOF#3 (1 mM lactate, 2.5 mM glucose)
120 h after fertilization. On day 7 post-fertilization, blas-
tocysts were collected, washed three times in nuclease-
free phosphate-buffered saline (PBS) and frozen at −80°C
until DNA extraction.
Day-12 elongated embryo collection
Day-12 elongated embryos were produced at Alliance
Boviteq inc. (Saint-Hyacinthe, QC, CAN). On days 8–12
post-oestrus, follicles with a diameter larger than 8 mm
were aspirated. Thirty-six hours later, FSH (Folltropin-V,
Bioniche Animal Health, Belleville, ON, CAN) wasadministered to fertile heifers. Overall, eight injections
were given, twice daily, for a total of 400 mg of FSH in de-
creasing doses starting from 60 mg for the first dose to
20 mg for the last dose. Two doses (500 μg each) of pros-
taglandin F2α analogue (Estrumate, Intervet, Kirkland,
QC, CAN) were administered with the two final FSH in-
jections to trigger luteolysis. The animals exhibited oestrus
about 36 h after the final FSH/Estrumate injection and
were inseminated twice, 12 h and 24 h post-oestrus. Em-
bryos were recovered by uterine flushing 12 days after the
first insemination. Two elongated embryos of good quality
were washed in nuclease-free (PBS) and frozen at −80°C
until DNA extraction.Extraction of embryo genomic DNA
A total of 1,090 blastocysts (Day 7) produced in vitro in
our lab and stored at −80°C were pooled prior to ge-
nomic DNA (gDNA) extraction in 500 μl of PBS. The
same procedures were followed for Day 12 embryos.
This volume was divided in two. Genomic DNA was
then extracted from each 250-μl fraction using the
“Micro protocol” from SwitchCharge extraction kit
(Invitrogen) with a final elution in 150 μl of Tris–HCl
(pH 8.5). The two resulting extractions were pooled. The
gDNA quality was determined by electrophoretic migra-
tion and the gDNA was stored at −20°C. This blastocyst
gDNA extraction was used to apply the three protocols
targeting methylated sequences. Additional pools of 60
blastocysts and Day-12 embryos were extracted using the
same protocol and used for q-PCR validation.Methylation-sensitive and Hydroxymethylation-sensitive
digestion of gDNA
To enrich the methylated fraction in CG-rich regions,
blastocyst and elongation-stage gDNAs were cleaved by
MspI (C/CGG-specific) to form Tester DNA or by its
methylcytosine-sensitive isoschizomer HpaII to form
Driver DNA. Samples containing 350 ng of DNA were
held for 12 h at 37°C with 10 U/μl MspI in 10× Buffer 4
or 20 U/μl HpaII in 10× Buffer 1 (New England Biolabs,
Ipswich, MA, USA), adding the enzymes in three doses.
DNA digests (100 ng) were analyzed by electrophoresis
confirm cleavage. To enrich the hydroxymethylated frac-
tion, cleavage was carried out as follows: 1) Tester – the
DNA sample was cleaved with FspBI (C/TAG-specific,
10 U in 2× Tango Buffer, Fermentas Life Sciences,
Lithuania) added in three doses, drawing into a
pipette to mix. 2) Driver – the sample was cleaved
with hydroxymethyl-sensitive isoschizomer BfaI (5 U in
10× NEB4, New England Biolabs) under the same condi-
tions. DNA digests (100 ng) were analyzed by
electrophoresis confirm cleavage. The remaining 250 ng
were stored at −20°C.
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The double-stranded GC-overhang J adaptor (for Me-
RDA) fits with MspI/HpaII ends, and the double-stran-
ded TA-overhang JTA adaptor (for HMe-RDA) fits with
BfaI ends. In order to use an enzyme cocktail to obtain
only –TA protruding ends, we designed adaptors creat-
ing a new BfaI/FspBI site allowing one-step adaptor re-
moval in all cases. Adaptor sequences are shown in
Table 5. The double-stranded adaptors were obtained
from Integrated DNA Technologies (Coralville, IA,
USA) and diluted in TE buffer (pH 8) to 60 pmol/μl.
Digested DNA previously purified using phenol-chloro-
form was dissolved in 10 μl of TE buffer. The ligation
mixture with 10 μl of purified digested DNA (~150 ng)
was mixed with 450 pmol of J duplex adaptor or JTA
duplex adaptor, 10X T4 DNA ligation buffer (New
England Biolabs) and water to obtain a total volume
of 30 μl. The reaction was started at 55°C and slowly
tempered until a temperature of 15-20°C was reached.
T4 DNA ligase kept on ice was added (400 U) and
the ligation reaction was performed in a thermal-
cycler at 16°C for 16 h. The ligation products were
diluted with 220 μl of TE buffer for subsequent
amplification.
Genome representational PCR
In order to generate sufficient amplified product for
subsequent subtraction steps, four representational PCR
amplifications for Tester and 14 for Driver were per-
formed using J-1A and JTA-1A primers. The reaction
mixture contained TaKaRa Mg2+-free 10X reaction buf-
fer (10 μl), 25-mM MgCl2 (6 μl), 2.5 mM dNTP
(12.8 μl), 120 pmol of primer, Ex Taq DNA polymerase
(10 U) plus 15 μl of diluted ligated DNA and water to a
final volume of 100 μl. The 30 amplification cycles
consisted of 1 min at 95°C, 1 min at 65°C and 1 min at
72°C for J-1B primer and 1 min at 95°C, 1 min at 65°C












AATT-1a 3′-------TAGACCATCAGTCAGAGTTAA-5′amplicons were pooled and cleaned twice with phenol-
chloroform for subsequent enzymatic cleavage of J and
JTA adaptors. Ten μg of cleaved Tester amplicons were
then loaded on 1.5% agarose gel, extracted and purified
using the Qiagen gel extraction kit (Qiagen) in order to
eliminate free J and JTA adaptors.
Hybridization and subtraction for Me-RDA and HMe-RDA
Before the subtraction step, additional N or NTA adap-
tors were ligated to Testers only. The double-stranded
GC-overhang N adaptor for Me-RDA and TA-overhang
NTA adaptor for Me-RDA cocktail (Table 5) fit respect-
ively MspI/HpaII and BfaI/FspBI ends. The ligation mix-
ture with 10 μl of purified Tester DNA (~1 μg) was
mixed with 450 pmol of N duplex adaptor or NTA du-
plex adaptor (60 pmol/μl), 10X T4 DNA ligation buffer
and water (total volume of 30 μl). The ligation reaction
was performed as described above. The ligation pro-
ducts were diluted with 50 μl of TE-solution contai-
ning 28 μg/ml tRNA for subsequent hybridization.
Tester (400 ng) and Driver DNA (40 μg) were co-
purified with phenol-chloroform and precipitated using
ammonium acetate and ethanol. The Tester-Driver co-
precipitate was dissolved in 5 μl of EEB buffer (Sigma
EPPS buffer 30 mM, pH 8 with 3 mM EDTA). After a
3-min denaturing step at 98°C, 1.5 μl of NaCl 5 M was
added. Hybridization was carried out for 24 h at 67°C in
a thermal cycler. The hybridization product was mixed
with 40 μg of tRNA and diluted with 190 μl of Tris-
EDTA. Subtractive amplification consisted of PCR for
ten cycles as described above but using N-1A or NTA-
1A primers, 10 μl of hybridization buffer, two tubes per
hybridization, pooled, purified with phenol-chloroform
and dissolved in 40 μl of TE, followed by digestion of
half of this material for 30 min at 30°C with 20 U of
mung bean nuclease (New England Biolabs) in order to
remove single-stranded DNA (in 10X buffer plus water
to 40 μl). Tris–HCl (50 mM, pH 8.9) was added and the
mixture was held at 98°C for 5 min to inactivate the nu-
clease. This amplification was repeated on 10 μl of mung
bean nuclease digest using the same N-1A and NTA-1A
primers, but with a 20-cycle PCR.
Digestion of gDNA and adaptor ligation for HELP cocktail
For targeting fragments preferentially outside of CpG
sites, blastocyst (Day 7) and Day 12 gDNA were cleaved
at 65°C with TasI enzyme (350 ng with 10 U in 2× Tango
Buffer, Fermentas Life Sciences) added in three doses
during the 12-h reaction. After testing by electrophore-
sis, the remaining 250 ng were stored at −20°C.
After TasI cleavage, the double-stranded adaptor resul-
ting from annealing of AATT-1a and AATT-1b oligo-
nucleotides (Schumacher, 2006; Table 5) was ligated
to AATT-overhangs under the same conditions as for
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mixed with 180 pmol of AATT-duplex adaptor (IDT),
10X T4 DNA ligation buffer (New England Biolabs)
and water to 30 μl. The ligation product was diluted
with 70 μl of water, mixed with 10 μg of tRNA, fur-
ther purified with phenol-chloroform and precipitated
in 20 μl of TE buffer for subsequent cleavage.
Methylation-sensitive cleavage for HELP cocktail
For enrichment of the 5mC hyper-methylated fraction
of the TasI cleavage product, a cocktail of three methyla-
tion-sensitive enzymes, HpaII (C/CGG), AciI (C/CGC)
and HinP1I (GC/GC) was used. AATT-ligated DNA from
blastocysts and Day 12 embryos, purified using phenol/
chloroform/isoamylic alcohol 25:24:1, was cleaved (~70 ng
in 14 μl) with 10 U/μl in 2X Tango Buffer, Fermentas Life
Sciences) for 12 h at 37°C. The methyl-sensitive digestions
were mixed with 10 μg of tRNA, further purified with
phenol-chloroform and precipitated in 20 μl of TE buffer
for subsequent PCR.
HELP cocktail PCR
PCR amplification of the purified DNA digest (~50 ng)
was also carried out with AATT-1b primer (120 pmol)
using TaKaRa Mg2+-free 10X reaction buffer (10 μl),
25-mM MgCl2 (8 μl), 2.5-mM dNTP (12.8 μl) and
TaqEx enzyme RR01AM (5 U), plus water to a final vol-
ume of 100 μl. The mixture was subjected to 25 cycles
of 1 min at 95°C, 1 min at 56°C and 2 min at 72°C.
q-PCR validation
Three additional pools of blastocysts and Day 12 em-
bryos were collected and genomic DNA extracted as de-
tailed above. Methylated site families in Me-RDA and
HELP, and hydroxymethylated site families in HMe-RDA
were selected following PCR quantification in methyl/
hydroxymethyl insensitive versus sensitive cleavage. Re-
verse and forward primers were designed using IDT
primerquest (http://eu.idtdna.com/Scitools/Applications/
Primerquest/) and the EmbryoGENE Genome Browser
(http://emb-bioinfo.fsaa.ulaval.ca/bioinfo/html/index.html)
tools. Primer sequence, annealing and fluorescence acqui-
sition temperatures, amplicon size and GeneBank acces-
sion numbers are shown in Additional file 1: Table S1.
The reaction mixture contained LightCycler 480 SYBR
Green I Master (Roche Diagnostics) and the threshold
cycle was detected using a LightCycler 480 (Roche Diag-
nostics). The amplicon melting curve profile and DNA se-
quence was also determined. The threshold cycle of the
same quantity (200 pg) of non-cleaved DNA with the re-
spective sensitive enzyme was determined and ΔCt was
calculated for analysis of the proportion of specific me-
thylation or hydroxymethylation for each restriction site.
Statistical validation was based on a simplified Wilcoxontwo-group test to compare the pools of each condi-
tion [70].Sequencing strategy
The product of the final amplification steps was puri-
fied using the Qiagen PCR purification kit (Qiagen,
Mississauga, ON, CAN) and quality was assessed using a
1-μl sample aliquot on an Agilent 7500 DNA chip on a
Lab-on-a-Chip 2100 Bioanalyser apparatus (Agilent Tech-
nologies, Mississauga, ON, CAN). The remainder of the
sample was used for pyro-sequencing using a Roche/454
Genome Sequencer FLX system. Sequencing results
are made available at http://emb-bioinfo.fsaa.ulaval.ca/
DeMontera2012/DiffMeth/Data/.Identification of putative methylated and
hydroxymethylated restriction sites
SeqClean (http://sourceforge.net/projects/seqclean/) and
the UniVec database [71] were used to remove adaptors
and scan for contaminants. HELP sequences were then
scanned for HpaII, AciI and HinP1I restriction sites
and reads lacking any of these sites were excluded. All
reads from each library were then clustered using the
USEARCH tool [72] with a 97% identity threshold. The
resulting consensus sequences were scanned for repeats
using RepeatMasker [[73] <http://www.repeatmasker.
org>] with build 20110920 of the RepBase database [74].
Consensus sequences were aligned to the UMD3.1 as-
sembly of the bovine genome [75] using BLAT [76].
Alignments with less than 92% identity over 92% of the
sequence length were discarded. When more than one
such alignment existed for a consensus sequence, all
alignments for this sequence were also excluded from
further analysis. To determine the location of putative
methylated or hydroxymethylated restriction sites, the
remaining aligned sequences were extended in silico to
the nearest restriction site of interest up to a maximum
of 1,000 bp. This means the nearest HpaII, FspBI and
TasI sites for Me-RDA, HMe-RDA and HELP Cocktail,
respectively. As the sites at both extremities of Me-RDA
and HMe-RDA fragments are potentially (hydroxy)
methylated, the CpGs at both ends of a fragment were
labeled as putatively methylated and hydroxymethylated,
respectively. For HELP Cocktail, the CpGs within all
HpaII, AciI and HinP1I restriction sites in-between the
identified TasI sites were labeled as potentially methyl-
ated sites. The set of all sites thus identified served as
the basis for further analysis. The source code of the
analysis pipeline described in this section can be ob-
tained at http://emb-bioinfo.fsaa.ulaval.ca/DeMontera2012/.
The alignment of reads and the identified sites can be visua-
lized within the bosTau6 assembly of the EmbryoGENE
genome browser at http://emb-bioinfo.fsaa.ulaval.ca/.
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Coverage graphs of the putative methylated and hydro-
xymethylated restrictions sites were generated using the
hgGenome tool from the UCSC Genome Browser [77].
Cytobands within these graphs are approximations adap-
ted from [38]. Using BEDTools [78], sites were further
categorized depending on whether they occurred within
inter-gene, exon, intron or promoter regions as defined
by the Gnomon annotation of the UMD3.1 assembly
of the bovine genome (ftp://ftp.cbcb.umd.edu/pub/data/
assembly/Bos_taurus/). Finally, the exon, intron and pro-
moter regions of each gene were grouped together so
that all sites were associated with a unique gene or
inter-gene region. Lists of library specific regions were
then compared, and Venn diagrams were generated
using the softwares of [79] and [80].
Availability of supporting data
The data sets supporting the results of this article are
available in the EmbryoGENE genome browser reposi-
tory, http://emb-bioinfo.fsaa.ulaval.ca/DeMontera2012/.
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